Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07020741 · ClinicalTrials.gov registry record · NA
Stable Isotopes- Adults With Obesity
A NA study of Glucose Metabolism and Protein Metabolism, sponsored by University of Illinois at Urbana-Champaign.
- Recruiting
- Registry status
- NA
- Development phase
- 8
- Enrollment target
- 1
- Study location
NCT07020741: Recruiting NA study of Glucose Metabolism and Protein Metabolism, sponsored by University of Illinois at Urbana-Champaign.
NCT07020741 is a NA study of Glucose Metabolism and Protein Metabolism that is actively recruiting participants, run by University of Illinois at Urbana-Champaign. The registered enrollment target is 8 participants, below the 58-participant average among 5 other Glucose Metabolism trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07020741, a NA study of Glucose Metabolism and Protein Metabolism, is actively recruiting participants, sponsored by University of Illinois at Urbana-Champaign.
- RECRUITING
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
In a crossover design, 8 participants will receive caloric drinks containing stable isotopes. In one arm of the study, participants will consume 6 hourly drinks containing two stable isotopes. Repeated blood, breath, urine, and muscle biopsies will be taken. In the second arm, participants will consume 1 drink containing 75g glucose, labeled with two stable isotopes of glucose. Periodic blood and breath will be taken over three hours.
Primary Outcome
Amino Acid Oxidation of phenylalanine will be measured using the IAAO method by periodic ingestion of amino acid mixture. Trials will start at \~7:00 am (-30 minutes) with a total duration of 6.5 hours (390 minutes) Measurements of breath (-30, 0, 120, 240, 270, 300, 330 and 360 minutes), Urine (-30, 0, 240, 300, and 360 minutes), muscle biopsy (-30 and 360 minutes) and blood (-30, 0, 30, 60, 90,120, 180, 240, 300, and 360 minutes) will be used to determine the whole body efficiency of protein i
Conditions Studied
Interventions
- PROCEDURE Indispensable Amino Acid Oxidation
- PROCEDURE Stable Isotope Oral Glucose Tolerance Test
Study Locations (1)
Illinois
- Freer Hall - University of Illinois - Urbana
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2025-09-12 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT07020741 shows while recruiting
NCT07020741 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 58-participant average among 5 other Glucose Metabolism trials with a reported enrollment target (86% lower).
The record links to 3 conditions, with Glucose Metabolism appearing as the primary indexed condition, and to 2 interventions - of which Indispensable Amino Acid Oxidation is the first listed.
NCT07020741 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT07020741 about?
NCT07020741 is a clinical study titled "Stable Isotopes- Adults With Obesity". In a crossover design, 8 participants will receive caloric drinks containing stable isotopes. In one arm of the study, participants will consume 6 hourly drinks containing two stable isotopes. Repeated blood, breath, urine, and muscle biopsies will be taken. In the second arm, participants will cons...
What is the current status of trial NCT07020741?
This trial is currently recruiting. It is a NA study. The enrollment target is 8 participants. The study started on 2025-09-12. Estimated completion is 2026-12-31.
What conditions does trial NCT07020741 study?
This clinical trial studies the following conditions: Glucose Metabolism, Protein Metabolism, Obese Patients (BMI ≥ 30 kg/m²).
What interventions are being tested in trial NCT07020741?
The interventions under investigation include: Indispensable Amino Acid Oxidation (PROCEDURE), Stable Isotope Oral Glucose Tolerance Test (PROCEDURE).
Who is sponsoring clinical trial NCT07020741?
This trial is sponsored by University of Illinois at Urbana-Champaign, which has 129 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07020741 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glucose Metabolism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
GENESIS: Genotype Guided - Natriuretic Peptides - Cardiometabolic Health Study
RECRUITING · NA
-
Evaluation of Biomarkers for Predicting Macronutrient Intake
RECRUITING · NA
-
StandUPTV Habits: Feasibility Trial for Maintaining Reductions in Sedentary Screen Time
RECRUITING · NA
-
Effect of Naringenin and Beta Carotene on Energy Expenditure
COMPLETED · NA
-
Impact of Passive Heat on Metabolic, Inflammatory and Vascular Health in Persons With Spinal Cord Injury
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI